Raymond James & Associates Vaxart, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Vaxart, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 12,279 shares of VXRT stock, worth $4,297. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,279

Previous 16,726 26.59%

Holding current value

$4,297

Previous $11,000 9.09%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$0.58 - $0.99 $2,579 - $4,402	-4,447 Reduced 26.59%	12,279 $10,000
Q2 2024 Jul 19, 2024	SELL	$0.53 - $1.3 $69 - $170	-131 Reduced 0.78%	16,726 $11,000
Q1 2024 Apr 22, 2024	SELL	$0.56 - $1.41 $73 - $184	-131 Reduced 0.77%	16,857 $21,000
Q4 2023 Jan 16, 2024	SELL	$0.57 - $0.85 $285 - $425	-500 Reduced 2.86%	16,988 $9,000
Q3 2023 Oct 24, 2023	SELL	$0.69 - $0.85 $172 - $212	-250 Reduced 1.41%	17,488 $13,000
Q2 2023 Jul 25, 2023	BUY	$0.6 - $1.41 $4,569 - $10,738	7,616 Added 75.24%	17,738 $12,000
Q1 2023 Apr 14, 2023	SELL	$0.71 - $1.25 $355 - $625	-500 Reduced 4.71%	10,122 $7,000
Q4 2022 Feb 08, 2023	SELL	$0.75 - $2.24 $1,703 - $5,087	-2,271 Reduced 17.61%	10,622 $10,000
Q3 2022 Oct 25, 2022	SELL	$2.09 - $4.5 $601 - $1,296	-288 Reduced 2.18%	12,893 $28,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $5.28 $777 - $1,520	288 Added 2.23%	13,181 $46,000
Q1 2022 May 11, 2022	SELL	$4.29 - $6.64 $1,179 - $1,826	-275 Reduced 2.09%	12,893 $65,000
Q4 2021 Feb 08, 2022	SELL	$5.77 - $7.96 $143,384 - $197,806	-24,850 Reduced 65.36%	13,168 $83,000
Q3 2021 Nov 02, 2021	BUY	$6.67 - $9.8 $667 - $980	100 Added 0.26%	38,018 $302,000
Q2 2021 Aug 11, 2021	BUY	$5.06 - $10.78 $37,383 - $79,642	7,388 Added 24.2%	37,918 $284,000
Q1 2021 May 14, 2021	SELL	$5.64 - $23.33 $41,662 - $172,338	-7,387 Reduced 19.48%	30,530 $185,000
Q4 2020 Feb 12, 2021	BUY	$3.5 - $7.98 $95,903 - $218,659	27,401 Added 260.56%	37,917 $217,000
Q3 2020 Nov 04, 2020	BUY	$4.78 - $16.97 $50,266 - $178,456	10,516 New	10,516 $70,000

Others Institutions Holding VXRT

# of Institutions

104

Shares Held

23.1M

Call Options Held

66.1K

Put Options Held

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $44.3M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Vaxart, Inc. Transaction History